Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

被引：0
|
作者：
O Nehls
B Klump
H T Arkenau
H G Hass
A Greschniok
M Gregor
R Porschen
机构：
[1] University Hospital,Department of Internal Medicine I
[2] University Hospital,Department of Pathology
[3] Clinic of Internal Medicine,undefined
[4] Central Hospital Bremen Ost,undefined
来源：
British Journal of Cancer | 2002年 / 87卷
关键词：
biliary carcinoma; chemotherapy; 5-fluorouracil; oxaliplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We studied the activity of combined oxaliplatin and fluorouracil-leucovorin in 16 consecutive patients with advanced biliary tract adenocarcinomas. The disease control rate (responses and stable disease) was 56% (95% confidence interval, 29–84%) and the median overall survival time was 9.5 months (range 0.9–26.8+). Therefore, this regimen might be active in biliary adenocarcinomas with further evaluation necessary.
引用
收藏
页码：702 / 704
页数：2
相关论文
共 50 条
  • [41] A phase II trial of etoposide, leucovorin and 5-fluorouracil (ELF) in patients with advanced gastric cancer
    Au, E
    Koo, WH
    Tan, EH
    Ang, PT
    JOURNAL OF CHEMOTHERAPY, 1996, 8 (04) : 300 - 303
  • [42] A phase II trial of 5-fluorouracil, leucovorin and mitomycin C in patients with advanced gastric cancer
    Kim, SR
    Yuh, YJ
    Kim, HJ
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 254 - 254
  • [43] Phase III Noninferiority Trial Comparing Irinotecan With Oxaliplatin, Fluorouracil, and Leucovorin in Patients With Advanced Colorectal Carcinoma Previously Treated With Fluorouracil: N9841
    Kim, George P.
    Sargent, Daniel J.
    Mahoney, Michelle R.
    Rowland, Kendrith M., Jr.
    Philip, Philip A.
    Mitchell, Edith
    Mathews, Abraham P.
    Fitch, Tom R.
    Goldberg, Richard M.
    Alberts, Steven R.
    Pitot, Henry C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (17) : 2848 - 2854
  • [44] Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer
    Kim, DY
    Kim, JH
    Lee, SH
    Kim, TY
    Heo, DS
    Bang, YJ
    Kim, NK
    ANNALS OF ONCOLOGY, 2003, 14 (03) : 383 - 387
  • [45] A phase II study of paclitaxel, oxaliplatin, leucovorin and 5-fluorouracil (POLF) in gemcitabine-refractory advanced pancreatic cancer
    Chue, Ben
    Grutsch, James
    Gupta, Digant
    Birdsall, John
    Lis, Christopher
    CANCER RESEARCH, 2009, 69
  • [46] The safety and efficacy of fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) combination in the front-line treatment for patients with advanced gastric or gastroesophageal adenocarcinoma: phase II trial
    Anter, Abeer Hussien
    Abdel-Latif, Rasha Mohamed
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [47] Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study
    B Neri
    P Pantaleo
    E Giommoni
    R Grifoni
    C Paoletti
    V Rotella
    D Pantalone
    A Taddei
    A Mercatelli
    P Tonelli
    British Journal of Cancer, 2007, 96 : 1043 - 1046
  • [48] Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study
    Pectasides, D
    Pectasides, A
    Farmakis, D
    Bountouroglou, N
    Nikolaou, M
    Koumpou, M
    Mylonakis, N
    Kosmas, C
    ANNALS OF ONCOLOGY, 2003, 14 (04) : 537 - 542
  • [49] Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study
    Neri, B.
    Pantaleo, P.
    Giommoni, E.
    Grifoni, R.
    Paoletti, C.
    Rotella, V.
    Pantalone, D.
    Taddei, A.
    Mercatelli, A.
    Tonelli, P.
    BRITISH JOURNAL OF CANCER, 2007, 96 (07) : 1043 - 1046
  • [50] The safety and efficacy of fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) combination in the front-line treatment for patients with advanced gastric or gastroesophageal adenocarcinoma: phase II trial
    Abeer Hussien Anter
    Rasha Mohamed Abdel-Latif
    Medical Oncology, 2013, 30
12345